DREVX
Price
$19.92
Change
+$0.03 (+0.15%)
Updated
Sep 20 closing price
RGAHX
Price
$75.98
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

DREVX vs RGAHX

Header iconDREVX vs RGAHX Comparison
Open Charts DREVX vs RGAHXBanner chart's image
BNY Mellon Large Cap Securities
Price$19.92
Change+$0.03 (+0.15%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$75.98
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DREVX vs RGAHX Comparison Chart
Loading...
VS
DREVX vs. RGAHX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DREVX is a Buy and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 290B vs. DREVX (2.39B). RGAHX pays higher dividends than DREVX: RGAHX (0.64) vs DREVX (0.29). DREVX was incepted earlier than RGAHX: DREVX (73 years) vs RGAHX (9 years). RGAHX is a more actively managed with annual turnover of: 31.00 vs. DREVX (29.08). RGAHX has a lower initial minimum investment than DREVX: RGAHX (250) vs DREVX (2500). RGAHX annual gain was more profitable for investors over the last year : 30.34 vs. DREVX (28.75). DREVX return over 5 years is better than : 67.78 vs. RGAHX (54.03).
DREVXRGAHXDREVX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence73 years9 years-
Gain YTD22.37821.860102%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.39B290B1%
Annual Yield % from dividends0.290.6445%
Returns for 1 year28.7530.3495%
Returns for 3 years21.290.792,708%
Returns for 5 years67.7854.03125%
Returns for 10 years64.89N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPTA8.760.16
+1.86%
Perpetua Resources Corp
YHGJ1.010.01
+1.01%
Yunhong Green CTI Ltd
ARQT10.150.01
+0.10%
Arcutis Biotherapeutics
MATX134.72-2.46
-1.79%
Matsons
CSGP77.36-1.93
-2.43%
CoStar Group